MARCH 2014 DELWAWARE DIAMOND CHAPTER NEWSLETTER
Hi All,
Hope everyone is well.
Please send me info that you would like to see in the newsletter.
Thank you.
Constance Hill
Your friendly newsletter writer.
NEXT DDCONS MEETING
Celgene Corporation cordially invites you to participate in a program titled:
The Role of REVLIMID® (lenalidomide)
in Relapsed or Refractory Mantle Cell Lymphoma
Presented by
Danielle Land, MSN,
CRNP
University of
Pennsylvania
Philadelphia, PA
Thursday, April
17, 2014
6:00 PM - 8:00
PM
Walter's
Steakhouse
802 North Union
Street
Wilmington, DE
19805
This is a promotional program and no CME credits are
offered.
Please RSVP to Mary Redman @
mredman@christianacare.org by 4/10/14
SITUATION WANTED
Camp nurse needed: the camp is located near Chestertown MD and sits on 300+ acres
with over a mile of Chesapeake Bay waterfront. July 28-August 8. You may help for one
or both weeks. DE or MD nursing license needed. Please email Michelle Burke-Kelley,
PA kburke@christianacare.org for more information.
ONE OF OUR OWN…
Understanding Complications Associated with
Understanding Complications Associated with
Multiple Myeloma: A Case Study-Based Program
Featured Speaker: Loretta Meck, MSN Medical Oncology Hematology Consultants
Newark, DE Krazy Kat's 528 Montchanin Rd Wilmington, DE 19710
Krazy Kat’s 528 Montchanin Rd Wilmington, DE 19710 Thursday, April 24, 2014 | 6:00
PM - 8:00
To register for this program, please reply to this e-mail with your name, degree,
institution, phone number, and e-mail address. YYou may also register by calling Lauren
Moore, Envision Communications, at (770)984-7086. If you have any questions about
this program, please contact the Celgene representative, Lucas Scheps, at (443)807-0032
or lscheps@celgene.com.
This is a non-CME disease-state program and no CME credits are offered.
ANOTHER OPPORTUNITY TO LEARN……
On behalf of Seattle Genetics, you are cordially
invited to an educational program titled:
PATIENT MANAGEMENT CONSIDERATIONS WITH ADCETRIS™
The purpose of the meeting will be to educate physicians and other healthcare practitioners on the
role of ADCETRIS (brentuximab vedotin) in the treatment of relapsed Hodgkin lymphoma and
systemic anaplastic large cell lymphoma.
Healthcare Professionals including Hematologist Oncologists, Medical Oncologists, Pathologists,
Pharmacists, PAs, NPs, and RNs are encouraged to participate in this valuable dialogue.
Event Date/Time: April 22, 2014 / 5:00 PM
Venue:
Kooma
400 Justison Street
Wilmington, DE
(302) 543-6732
Featured Speaker: Barbara Rogers, CRNP, MN, AOCN, ANP-BC Temple Fox Chase Cancer Center
To RSVP or for information regarding ADCETRIS, contact your local Seattle Genetics Account
Manager, Swati Navani at
(609) 955-1038 or snavani@seagen.com.